Recent updates emphasize earlier screening and refined risk stratification:
Dyslipidemia is primarily driven by either genetic (primary) or acquired (secondary) factors.
Dyslipidemias represent a spectrum of metabolic disorders characterized by abnormal levels of lipids in the blood, including cholesterol and triglycerides. As of 2026, clinical focus has shifted significantly toward aggressive LDL-C reduction and the integration of non-HDL-C as a primary therapeutic target. Understanding Dyslipidemias: Pathophysiology
Welcome to the Tales of Graces Fan Translation website. This website compiles news, information, and updates about the progress of the patch. Up-to-date progress reports are available on the right of this page, and some roadmap landmarks and milestones that can't be displayed in neat little bars are present below.
Please take a look around, and join us on our IRC Chat to talk directly to the developers and the community. Download DyslipidГ©mies pdf
The translation team gets a small portion of any sales made through these links. Recent updates emphasize earlier screening and refined risk